Literature DB >> 20797985

Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure.

Tariq Hamid1, Shang Z Guo, Justin R Kingery, Xilin Xiang, Buddhadeb Dawn, Sumanth D Prabhu.   

Abstract

AIMS: the role of nuclear factor (NF)-κB in heart failure (HF) is not well defined. We sought to determine whether myocyte-localized NF-κB p65 activation in HF exacerbates post-infarction remodelling and promotes maladaptive endoplasmic reticulum (ER) stress. METHODS AND
RESULTS: non-transgenic (NTg) and transgenic (Tg) mice with myocyte-restricted overexpression of a phosphorylation-resistant inhibitor of κBα (IκBα(S32A,S36A)) underwent coronary ligation (to induce HF) or sham operation. Over 4 weeks, the remote myocardium of ligated hearts exhibited robust NF-κB activation that was almost exclusively p65 beyond 24 h. Compared with sham at 4 weeks, NTg HF hearts were dilated and dysfunctional, and exhibited hypertrophy, fibrosis, up-regulation of inflammatory cytokines, increased apoptosis, down-regulation of ER protein chaperones, and up-regulation of the ER stress-activated pro-apoptotic factor CHOP. Compared with NTg HF, Tg-IκBα(S32A,S36A) HF mice exhibited: (i) improved survival, chamber remodelling, systolic function, and pulmonary congestion, (ii) markedly diminished NF-κB p65 activation, cytokine expression, and fibrosis, and (iii) a three-fold reduction in apoptosis. Moreover, Tg-IκBα(S32A,S36A) HF hearts exhibited maintained expression of ER chaperones and CHOP when compared with sham. In cardiomyocytes, NF-κB activation was required for ER stress-mediated apoptosis, whereas abrogation of myocyte NF-κB shifted the ER stress response to one of adaptation and survival.
CONCLUSION: persistent myocyte NF-κB p65 activation in HF exacerbates cardiac remodelling by imparting pro-inflammatory, pro-fibrotic, and pro-apoptotic effects. p65 modulation of cell death in HF may occur in part from NF-κB-mediated transformation of the ER stress response from one of adaptation to one of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20797985      PMCID: PMC3002872          DOI: 10.1093/cvr/cvq274

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  34 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Inflammatory mediators and the failing heart: past, present, and the foreseeable future.

Authors:  Douglas L Mann
Journal:  Circ Res       Date:  2002-11-29       Impact factor: 17.367

3.  Is nuclear factor kappaB an attractive therapeutic target for treating cardiac hypertrophy?

Authors:  Nicole H Purcell; Jeffery D Molkentin
Journal:  Circulation       Date:  2003-08-12       Impact factor: 29.690

Review 4.  Shaping the nuclear action of NF-kappaB.

Authors:  Lin-Feng Chen; Warner C Greene
Journal:  Nat Rev Mol Cell Biol       Date:  2004-05       Impact factor: 94.444

5.  Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support.

Authors:  Florian Grabellus; Bodo Levkau; Andrea Sokoll; Hendryk Welp; Christof Schmid; Mario C Deng; Atsushi Takeda; Günter Breithardt; Hideo A Baba
Journal:  Cardiovasc Res       Date:  2002-01       Impact factor: 10.787

6.  The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1.

Authors:  Haihong Zhong; Michael J May; Eijiro Jimi; Sankar Ghosh
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

7.  Beta-adrenergic receptor blockade modulates Bcl-X(S) expression and reduces apoptosis in failing myocardium.

Authors:  Sumanth D Prabhu; Guangwu Wang; Jianzhu Luo; Yan Gu; Peipei Ping; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2003-05       Impact factor: 5.000

8.  Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50.

Authors:  F Driessler; K Venstrom; R Sabat; K Asadullah; A J Schottelius
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

Review 9.  Nuclear factor-kappaB: its role in health and disease.

Authors:  Ashok Kumar; Yasunari Takada; Aladin M Boriek; Bharat B Aggarwal
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

10.  Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.

Authors:  Ken-ichiro Okada; Tetsuo Minamino; Yoshitane Tsukamoto; Yulin Liao; Osamu Tsukamoto; Seiji Takashima; Akio Hirata; Masashi Fujita; Yoko Nagamachi; Takeshi Nakatani; Chikao Yutani; Kentaro Ozawa; Satoshi Ogawa; Hitonobu Tomoike; Masatsugu Hori; Masafumi Kitakaze
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690

View more
  93 in total

1.  Interaction between NFκB and NFAT coordinates cardiac hypertrophy and pathological remodeling.

Authors:  Qinghang Liu; Yi Chen; Mannix Auger-Messier; Jeffery D Molkentin
Journal:  Circ Res       Date:  2012-03-08       Impact factor: 17.367

Review 2.  Endoplasmic reticulum stress: a novel mechanism and therapeutic target for cardiovascular diseases.

Authors:  Mei-qing Liu; Zhe Chen; Lin-xi Chen
Journal:  Acta Pharmacol Sin       Date:  2016-02-01       Impact factor: 6.150

3.  Nuclear factor κB inhibition reduces lung vascular lumen obliteration in severe pulmonary hypertension in rats.

Authors:  Daniela Farkas; Aysar A Alhussaini; Donatas Kraskauskas; Vita Kraskauskiene; Carlyne D Cool; Mark R Nicolls; Ramesh Natarajan; Laszlo Farkas
Journal:  Am J Respir Cell Mol Biol       Date:  2014-09       Impact factor: 6.914

4.  NF-κB activation is cell type-specific in the heart.

Authors:  Efraín E Rivera-Serrano; Barbara Sherry
Journal:  Virology       Date:  2016-12-30       Impact factor: 3.616

5.  Intramyocardial administration of chimeric ephrinA1-Fc promotes tissue salvage following myocardial infarction in mice.

Authors:  Jessica L Dries; Susan D Kent; Jitka A I Virag
Journal:  J Physiol       Date:  2011-01-31       Impact factor: 5.182

6.  P2X7 receptor regulates sympathoexcitatory response in myocardial infarction rats via NF-κB and MAPK pathways.

Authors:  Qin Wu; Hongtao Xu; Ling Hao; Guifang Ma; Jinxia Sun; Xianghe Song; Fengyun Ding; Nan Wang
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

7.  Methylsulfonylmethane decreases inflammatory response to tumor necrosis factor-α in cardiac cells.

Authors:  Lindsey E Miller
Journal:  Am J Cardiovasc Dis       Date:  2018-06-15

8.  Cardiomyocyte p65 nuclear factor-κB is necessary for compensatory adaptation to pressure overload.

Authors:  Hadi Javan; Amanda M Szucsik; Ling Li; Christin L Schaaf; Mohamed E Salama; Craig H Selzman
Journal:  Circ Heart Fail       Date:  2014-12-05       Impact factor: 8.790

Review 9.  Redox signaling in cardiovascular health and disease.

Authors:  Nageswara R Madamanchi; Marschall S Runge
Journal:  Free Radic Biol Med       Date:  2013-04-11       Impact factor: 7.376

10.  Do multiple nuclear factor kappa B activation mechanisms explain its varied effects in the heart?

Authors:  Rajesh Kumar; Qian Chen Yong; Candice M Thomas
Journal:  Ochsner J       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.